151 related articles for article (PubMed ID: 38167059)
21. Shikonin suppresses pulmonary fibroblasts proliferation and activation by regulating Akt and p38 MAPK signaling pathways.
Nie Y; Yang Y; Zhang J; Cai G; Chang Y; Chai G; Guo C
Biomed Pharmacother; 2017 Nov; 95():1119-1128. PubMed ID: 28922731
[TBL] [Abstract][Full Text] [Related]
22. Induction of G2/M Cell Cycle Arrest via p38/p21
Pai JT; Hsu MW; Leu YL; Chang KT; Weng MS
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500594
[TBL] [Abstract][Full Text] [Related]
23. Shikonin blocks human lung adenocarcinoma cell migration and invasion in the inflammatory microenvironment via the IL‑6/STAT3 signaling pathway.
Pan T; Zhang F; Li F; Gao X; Li Z; Li X; Ren X
Oncol Rep; 2020 Sep; 44(3):1049-1063. PubMed ID: 32705271
[TBL] [Abstract][Full Text] [Related]
24. Shikonin inhibits the proliferation of human lens epithelial cells by inducing apoptosis through ROS and caspase-dependent pathway.
Huang WR; Zhang Y; Tang X
Molecules; 2014 Jun; 19(6):7785-97. PubMed ID: 24962386
[TBL] [Abstract][Full Text] [Related]
25. Shikonin enhances sensitization of gefitinib against wild-type EGFR non-small cell lung cancer via inhibition PKM2/stat3/cyclinD1 signal pathway.
Tang JC; Ren YG; Zhao J; Long F; Chen JY; Jiang Z
Life Sci; 2018 Jul; 204():71-77. PubMed ID: 29738778
[TBL] [Abstract][Full Text] [Related]
26. Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway.
Pan L; Tan Y; Wang B; Qiu W; Yin Y; Ge H; Zhu H
Cancer Res Treat; 2020 Jul; 52(3):867-885. PubMed ID: 32164050
[TBL] [Abstract][Full Text] [Related]
27. Shikonin inhibits proliferation of melanoma cells by MAPK pathway-mediated induction of apoptosis.
Lee JH; Han SH; Kim YM; Kim SH; Yoo ES; Woo JS; Jung GH; Jung SH; Kim BS; Jung JY
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33403388
[TBL] [Abstract][Full Text] [Related]
28. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
[TBL] [Abstract][Full Text] [Related]
29. A natural anthraquinone derivative shikonin synergizes with AZD9291 against wtEGFR NSCLC cells through reactive oxygen species-mediated endoplasmic reticulum stress.
Hu X; Zhang ZY; Wu LW; Zeng LH; Chen H; Zhu HJ; Zhang JK; Shao J; Zhang C; Li YL; Lin NM
Phytomedicine; 2020 Mar; 68():153189. PubMed ID: 32070867
[TBL] [Abstract][Full Text] [Related]
30. IL-17A/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via p38 MAPK signaling pathway in non-small cell lung cancer.
Wu Z; He D; Zhao S; Wang H
Mol Cell Biochem; 2019 May; 455(1-2):195-206. PubMed ID: 30564960
[TBL] [Abstract][Full Text] [Related]
31. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.
Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX
Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829
[TBL] [Abstract][Full Text] [Related]
32. Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells.
Tung CL; Jian YJ; Chen JC; Wang TJ; Chen WC; Zheng HY; Chang PY; Liao KS; Lin YW
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):657-66. PubMed ID: 27026405
[TBL] [Abstract][Full Text] [Related]
33. 2,6-DMBQ suppresses cell proliferation and migration via inhibiting mTOR/AKT and p38 MAPK signaling pathways in NSCLC cells.
Xie X; Zu X; Laster K; Dong Z; Kim DJ
J Pharmacol Sci; 2021 Mar; 145(3):279-288. PubMed ID: 33602509
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological Activity of Matrine in Inhibiting Colon Cancer Cells VM Formation, Proliferation, and Invasion by Downregulating Claudin-9 Mediated EMT Process and MAPK Signaling Pathway.
Du Q; Lin Y; Ding C; Wu L; Xu Y; Feng Q
Drug Des Devel Ther; 2023; 17():2787-2804. PubMed ID: 37719361
[TBL] [Abstract][Full Text] [Related]
35. Transcriptome Analysis of the Inhibitory Effects of 20(S)-Protopanaxadiol on NCI-H1299 Non-Small Cell Lung Cancer Cells.
Cong Z; Zhang X; Lv Z; Jiang J; Wang L; Li J; Wang J; Zhao J
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570716
[TBL] [Abstract][Full Text] [Related]
36. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I.
Li L; Wu J; Zheng F; Tang Q; Wu W; Hann SS
J Exp Clin Cancer Res; 2016 Jul; 35(1):112. PubMed ID: 27421653
[TBL] [Abstract][Full Text] [Related]
38. Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway.
Lin M; Bi H; Yan Y; Huang W; Zhang G; Zhang G; Tang S; Liu Y; Zhang L; Ma J; Zhang J
Oncotarget; 2017 Apr; 8(14):23436-23447. PubMed ID: 28423582
[TBL] [Abstract][Full Text] [Related]
39. Shikonin induces apoptosis and G0/G1 phase arrest of gallbladder cancer cells via the JNK signaling pathway.
Zhai T; Hei Z; Ma Q; Liang H; Xu Y; Zhang Y; Jin L; Han C; Wang J
Oncol Rep; 2017 Dec; 38(6):3473-3480. PubMed ID: 29039581
[TBL] [Abstract][Full Text] [Related]
40. Reactive oxygen species-mediated activation of the Akt/ASK1/p38 signaling cascade and p21(Cip1) downregulation are required for shikonin-induced apoptosis.
Ahn J; Won M; Choi JH; Kim YS; Jung CR; Im DS; Kyun ML; Lee K; Song KB; Chung KS
Apoptosis; 2013 Jul; 18(7):870-81. PubMed ID: 23546866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]